Interleukin-1 receptor 1 knockout has no effect on amyloid deposition in Tg2576 mice and does not alter efficacy following Aβ immunotherapy

Por Das, Pritam, Smithson, Lisa A, Price, Robert W, Holloway, Vallie M, Levites, Yona, Chakrabarty, Paramita, Golde, Todd E
Publicado em 2006

Anti-Aβ(42)- and anti-Aβ(40)-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model

Por Levites, Yona, Das, Pritam, Price, Robert W., Rochette, Marjorie J., Kostura, Lisa A., McGowan, Eileen M., Murphy, Michael P., Golde, Todd E.
Publicado em 2006

Novel rat Alzheimer's disease models based on AAV-mediated gene transfer to selectively increase hippocampal Aβ levels

Por Lawlor, Patricia A, Bland, Ross J, Das, Pritam, Price, Robert W, Holloway, Vallie, Smithson, Lisa, Dicker, Bridget L, During, Matthew J, Young, Deborah, Golde, Todd E
Publicado em 2007

BRI2 (ITM2b) Inhibits Aβ Deposition In Vivo

Por Kim, Jungsu, Miller, Victor M., Levites, Yona, West, Karen Jansen, Zwizinski, Craig W., Moore, Brenda D., Troendle, Fredrick J., Bann, Maralyssa, Verbeeck, Christophe, Price, Robert W., Smithson, Lisa, Sonoda, Leilani, Wagg, Kayleigh, Rangachari, Vijayaraghavan, Zou, Fanggeng, Younkin, Steven G., Graff-Radford, Neill, Dickson, Dennis, Rosenberry, Terrone, Golde, Todd E.
Publicado em 2008

Substrate-targeting γ-secretase modulators

Por Kukar, Thomas L., Ladd, Thomas B., Bann, Maralyssa A., Fraering, Patrick C., Narlawar, Rajeshwar, Maharvi, Ghulam M., Healy, Brent, Chapman, Robert, Welzel, Alfred T., Price, Robert W., Moore, Brenda, Rangachari, Vijayaraghavan, Cusack, Bernadette, Eriksen, Jason, Jansen-West, Karen, Verbeeck, Christophe, Yager, Debra, Eckman, Christopher, Ye, Wenjuan, Sagi, Sarah, Cottrell, Barbara A., Torpey, Justin, Rosenberry, Terrone L., Fauq, Abdul, Wolfe, Michael S., Schmidt, Boris, Walsh, Dominic M., Koo, Edward H., Golde, Todd E.
Publicado em 2008